{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T19:43:12Z","timestamp":1772134992973,"version":"3.50.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T00:00:00Z","timestamp":1568851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T00:00:00Z","timestamp":1568851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Spinal and bulbar muscular atrophy (SBMA) is a neuromuscular disease caused by an expanded CAG repeat in the androgen receptor (AR) gene. Here, we perform a comprehensive analysis of signaling pathways in a mouse model of SBMA (AR-97Q mice) utilizing a phosphoprotein assay. We measure the levels of 17 phosphorylated proteins in spinal cord and skeletal muscle of AR-97Q mice at three stages. The level of phosphorylated Src (p-Src) is markedly increased in the spinal cords and skeletal muscles of AR-97Q mice prior to the onset. Intraperitoneal administration of a Src kinase inhibitor improves the behavioral and histopathological phenotypes of the transgenic mice. We identify p130Cas as an effector molecule of Src and show that the phosphorylated p130Cas is elevated in murine and cellular models of SBMA. These results suggest that Src kinase inhibition is a potential therapy for SBMA.<\/jats:p>","DOI":"10.1038\/s41467-019-12282-7","type":"journal-article","created":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T06:04:13Z","timestamp":1568873053000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Src inhibition attenuates polyglutamine-mediated neuromuscular degeneration in spinal and bulbar muscular atrophy"],"prefix":"10.1038","volume":"10","author":[{"given":"Madoka","family":"Iida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Sahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohide","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Nakatsuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genki","family":"Tohnai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Tsutsumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiya","family":"Noda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayuka","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunari","family":"Onodera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohei","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1838-4837","authenticated-orcid":false,"given":"Masahiro","family":"Nakatochi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Tsukagoshi Okabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinobu","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9302-4663","authenticated-orcid":false,"given":"Hiroaki","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyuki","family":"Okano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4769-5922","authenticated-orcid":false,"given":"Gen","family":"Sobue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9453-9311","authenticated-orcid":false,"given":"Masahisa","family":"Katsuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,9,19]]},"reference":[{"key":"12282_CR1","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1212\/WNL.18.7.671","volume":"18","author":"WR Kennedy","year":"1968","unstructured":"Kennedy, W. R., Alter, M. & Sung, J. H. Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait. Neurology 18, 671\u2013680 (1968).","journal-title":"Neurology"},{"issue":"Pt 1","key":"12282_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/brain\/112.1.209","volume":"112","author":"G Sobue","year":"1989","unstructured":"Sobue, G. et al. X-linked recessive bulbospinal neuronopathy. A clinicopathological study. Brain 112(Pt 1), 209\u2013232 (1989).","journal-title":"Brain"},{"key":"12282_CR3","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.pneurobio.2012.05.007","volume":"99","author":"M Katsuno","year":"2012","unstructured":"Katsuno, M. et al. Pathogenesis and therapy of spinal and bulbar muscular atrophy (SBMA). Prog. Neurobiol. 99, 246\u2013256 (2012).","journal-title":"Prog. Neurobiol."},{"key":"12282_CR4","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1093\/brain\/awl096","volume":"129","author":"N Atsuta","year":"2006","unstructured":"Atsuta, N. et al. Natural history of spinal and bulbar muscular atrophy (SBMA): a study of 223 Japanese patients. Brain 129, 1446\u20131455 (2006).","journal-title":"Brain"},{"key":"12282_CR5","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s12031-015-0674-7","volume":"58","author":"KH Fischbeck","year":"2016","unstructured":"Fischbeck, K. H. Spinal and bulbar muscular atrophy overview. J. Mol. Neurosci. 58, 317\u2013320 (2016).","journal-title":"J. Mol. Neurosci."},{"key":"12282_CR6","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1136\/jnnp-2017-316015","volume":"88","author":"A Hashizume","year":"2017","unstructured":"Hashizume, A. et al. Long-term treatment with leuprorelin for spinal and bulbar muscular atrophy: natural history-controlled study. J. Neurol. Neurosurg. Psychiatry 88, 1026\u20131032 (2017).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"12282_CR7","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/S1474-4422(10)70182-4","volume":"9","author":"M Katsuno","year":"2010","unstructured":"Katsuno, M. et al. Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 9, 875\u2013884 (2010).","journal-title":"Lancet Neurol."},{"key":"12282_CR8","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jns.2007.08.012","volume":"264","author":"G Soraru","year":"2008","unstructured":"Soraru, G. et al. Spinal and bulbar muscular atrophy: skeletal muscle pathology in male patients and heterozygous females. J. Neurol. Sci. 264, 100\u2013105 (2008).","journal-title":"J. Neurol. Sci."},{"key":"12282_CR9","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1172\/JCI28773.","volume":"116","author":"Z Yu","year":"2006","unstructured":"Yu, Z. et al. Androgen-dependent pathology demonstrates myopathic contribution to the Kennedy disease phenotype in a mouse knock-in model. J. Clin. Invest 116, 2663\u20132672 (2006).","journal-title":"J. Clin. Invest"},{"key":"12282_CR10","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.2119\/molmed.2012.00271","volume":"18","author":"C Rinaldi","year":"2012","unstructured":"Rinaldi, C. et al. Insulinlike growth factor (IGF)-1 administration ameliorates disease manifestations in a mouse model of spinal and bulbar muscular atrophy. Mol. Med 18, 1261\u20131268 (2012).","journal-title":"Mol. Med"},{"key":"12282_CR11","doi-asserted-by":"publisher","first-page":"18259","DOI":"10.1073\/pnas.0705501104","volume":"104","author":"DA Monks","year":"2007","unstructured":"Monks, D. A. et al. Overexpression of wild-type androgen receptor in muscle recapitulates polyglutamine disease. Proc. Natl Acad. Sci. USA 104, 18259\u201318264 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"12282_CR12","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.neuron.2014.03.001","volume":"82","author":"CJ Cortes","year":"2014","unstructured":"Cortes, C. J. et al. Muscle expression of mutant androgen receptor accounts for systemic and motor neuron disease phenotypes in spinal and bulbar muscular atrophy. Neuron 82, 295\u2013307 (2014).","journal-title":"Neuron"},{"key":"12282_CR13","doi-asserted-by":"publisher","first-page":"5985","DOI":"10.1093\/hmg\/ddv300","volume":"24","author":"K Sahashi","year":"2015","unstructured":"Sahashi, K. et al. Silencing neuronal mutant androgen receptor in a mouse model of spinal and bulbar muscular atrophy. Hum. Mol. Genet 24, 5985\u20135994 (2015).","journal-title":"Hum. Mol. Genet"},{"key":"12282_CR14","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.celrep.2014.02.008","volume":"7","author":"AP Lieberman","year":"2014","unstructured":"Lieberman, A. P. et al. Peripheral androgen receptor gene suppression rescues disease in mouse models of spinal and bulbar muscular atrophy. Cell Rep. 7, 774\u2013784 (2014).","journal-title":"Cell Rep."},{"key":"12282_CR15","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1002\/acn3.324","volume":"3","author":"Y Hijikata","year":"2016","unstructured":"Hijikata, Y. et al. Impaired muscle uptake of creatine in spinal and bulbar muscular atrophy. Ann. Clin. Transl. Neurol. 3, 537\u2013546 (2016).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"12282_CR16","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/0092-8674(95)90405-0","volume":"80","author":"T Hunter","year":"1995","unstructured":"Hunter, T. Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell 80, 225\u2013236 (1995).","journal-title":"Cell"},{"key":"12282_CR17","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1038\/nm.2932","volume":"18","author":"M Minamiyama","year":"2012","unstructured":"Minamiyama, M. et al. Naratriptan mitigates CGRP1-associated motor neuron degeneration caused by an expanded polyglutamine repeat tract. Nat. Med. 18, 1531\u20131538 (2012).","journal-title":"Nat. Med."},{"key":"12282_CR18","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1093\/hmg\/ddu445","volume":"24","author":"M Iida","year":"2015","unstructured":"Iida, M. et al. Pioglitazone suppresses neuronal and muscular degeneration caused by polyglutamine-expanded androgen receptors. Hum. Mol. Genet. 24, 314\u2013329 (2015).","journal-title":"Hum. Mol. Genet"},{"key":"12282_CR19","doi-asserted-by":"publisher","first-page":"e19309","DOI":"10.1371\/journal.pone.0019309","volume":"6","author":"JD Bjorge","year":"2011","unstructured":"Bjorge, J. D. et al. Simultaneous siRNA targeting of Src and downstream signaling molecules inhibit tumor formation and metastasis of a human model breast cancer cell line. PLoS ONE 6, e19309 (2011).","journal-title":"PLoS ONE"},{"key":"12282_CR20","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1634\/theoncologist.2009-0009","volume":"14","author":"DL Wheeler","year":"2009","unstructured":"Wheeler, D. L., Iida, M. & Dunn, E. F. The role of Src in solid tumors. Oncologist 14, 667\u2013678 (2009).","journal-title":"Oncologist"},{"key":"12282_CR21","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.ejcb.2014.07.002","volume":"93","author":"R Janostiak","year":"2014","unstructured":"Janostiak, R., Pataki, A. C., Brabek, J. & Rosel, D. Mechanosensors in integrin signaling: the emerging role of p130Cas. Eur. J. Cell Biol. 93, 445\u2013454 (2014).","journal-title":"Eur. J. Cell Biol."},{"key":"12282_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gene.2015.02.027","volume":"562","author":"P Camacho Leal Mdel","year":"2015","unstructured":"Camacho Leal Mdel, P. et al. p130Cas\/BCAR1 scaffold protein in tissue homeostasis and pathogenesis. Gene 562, 1\u20137 (2015).","journal-title":"Gene"},{"key":"12282_CR23","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1158\/1535-7163.MCT-08-0126","volume":"7","author":"A Vultur","year":"2008","unstructured":"Vultur, A. et al. SKI-606 (bosutinib), a novel Src kinase inhibitor, suppresses migration and invasion of human breast cancer cells. Mol. Cancer Ther. 7, 1185\u20131194 (2008).","journal-title":"Mol. Cancer Ther."},{"key":"12282_CR24","doi-asserted-by":"crossref","first-page":"24249","DOI":"10.1016\/S0021-9258(18)54220-4","volume":"266","author":"M Okada","year":"1991","unstructured":"Okada, M., Nada, S., Yamanashi, Y., Yamamoto, T. & Nakagawa, H. CSK: a protein-tyrosine kinase involved in regulation of src family kinases. J. Biol. Chem. 266, 24249\u201324252 (1991).","journal-title":"J. Biol. Chem."},{"key":"12282_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2005.03.012","volume":"331","author":"R Roskoski Jr.","year":"2005","unstructured":"Roskoski, R. Jr. Src kinase regulation by phosphorylation and dephosphorylation. Biochem. Biophys. Res. Commun. 331, 1\u201314 (2005).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"12282_CR26","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.7150\/ijbs.5141","volume":"8","author":"M Okada","year":"2012","unstructured":"Okada, M. Regulation of the SRC family kinases by Csk. Int J. Biol. Sci. 8, 1385\u20131397 (2012).","journal-title":"Int J. Biol. Sci."},{"key":"12282_CR27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0960-0760(02)00264-9","volume":"83","author":"A Migliaccio","year":"2002","unstructured":"Migliaccio, A. et al. Sex steroid hormones act as growth factors. J. Steroid Biochem. Mol. Biol. 83, 31\u201335 (2002).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"12282_CR28","doi-asserted-by":"publisher","first-page":"7979","DOI":"10.1038\/sj.onc.1208076","volume":"23","author":"MA Shupnik","year":"2004","unstructured":"Shupnik, M. A. Crosstalk between steroid receptors and the c-Src-receptor tyrosine kinase pathways: implications for cell proliferation. Oncogene 23, 7979\u20137989 (2004).","journal-title":"Oncogene"},{"key":"12282_CR29","doi-asserted-by":"publisher","first-page":"6619","DOI":"10.1038\/sj.onc.1210487","volume":"26","author":"A Migliaccio","year":"2007","unstructured":"Migliaccio, A. et al. Inhibition of the SH3 domain-mediated binding of Src to the androgen receptor and its effect on tumor growth. Oncogene 26, 6619\u20136629 (2007).","journal-title":"Oncogene"},{"key":"12282_CR30","doi-asserted-by":"publisher","first-page":"5636","DOI":"10.1038\/sj.onc.1203912","volume":"19","author":"RB Irby","year":"2000","unstructured":"Irby, R. B. & Yeatman, T. J. Role of Src expression and activation in human cancer. Oncogene 19, 5636\u20135642 (2000).","journal-title":"Oncogene"},{"key":"12282_CR31","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/0092-8674(91)90499-O","volume":"64","author":"P Soriano","year":"1991","unstructured":"Soriano, P., Montgomery, C., Geske, R. & Bradley, A. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64, 693\u2013702 (1991).","journal-title":"Cell"},{"key":"12282_CR32","doi-asserted-by":"crossref","unstructured":"Kaushik, S. & Cuervo, A. M. The coming of age of chaperone-mediated autophagy. Nat. Rev. Mol. Cell Biol. 19, 365\u2013381 (2018).","DOI":"10.1038\/s41580-018-0001-6"},{"key":"12282_CR33","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.cytogfr.2017.05.006","volume":"37","author":"S Mertsch","year":"2017","unstructured":"Mertsch, S. & Kramer, O. H. The interplay between histone deacetylases and rho kinases is important for cancer and neurodegeneration. Cytokine Growth Factor Rev. 37, 29\u201345 (2017).","journal-title":"Cytokine Growth Factor Rev."},{"key":"12282_CR34","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s002400000111","volume":"28","author":"Z Culig","year":"2000","unstructured":"Culig, Z., Hobisch, A., Bartsch, G. & Klocker, H. Androgen receptor\u2013an update of mechanisms of action in prostate cancer. Urol. Res. 28, 211\u2013219 (2000).","journal-title":"Urol. Res."},{"key":"12282_CR35","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nrc801","volume":"2","author":"SR Denmeade","year":"2002","unstructured":"Denmeade, S. R. & Isaacs, J. T. A history of prostate cancer treatment. Nat. Rev. Cancer 2, 389\u2013396 (2002).","journal-title":"Nat. Rev. Cancer"},{"key":"12282_CR36","doi-asserted-by":"publisher","first-page":"10449","DOI":"10.1158\/0008-5472.CAN-06-2582","volume":"66","author":"SJ Desai","year":"2006","unstructured":"Desai, S. J., Ma, A. H., Tepper, C. G., Chen, H. W. & Kung, H. J. Inappropriate activation of the androgen receptor by nonsteroids: involvement of the Src kinase pathway and its therapeutic implications. Cancer Res. 66, 10449\u201310459 (2006).","journal-title":"Cancer Res"},{"key":"12282_CR37","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ccr.2006.08.021","volume":"10","author":"Z Guo","year":"2006","unstructured":"Guo, Z. et al. Regulation of androgen receptor activity by tyrosine phosphorylation. Cancer Cell 10, 309\u2013319 (2006).","journal-title":"Cancer Cell"},{"key":"12282_CR38","doi-asserted-by":"publisher","first-page":"5406","DOI":"10.1093\/emboj\/19.20.5406","volume":"19","author":"A Migliaccio","year":"2000","unstructured":"Migliaccio, A. et al. Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation. EMBO J. 19, 5406\u20135417 (2000).","journal-title":"EMBO J."},{"key":"12282_CR39","doi-asserted-by":"publisher","first-page":"6862","DOI":"10.18632\/oncotarget.3119","volume":"6","author":"JC Zarif","year":"2015","unstructured":"Zarif, J. C., Lamb, L. E., Schulz, V. V., Nollet, E. A. & Miranti, C. K. Androgen receptor non-nuclear regulation of prostate cancer cell invasion mediated by Src and matriptase. Oncotarget 6, 6862\u20136876 (2015).","journal-title":"Oncotarget"},{"key":"12282_CR40","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.gde.2012.01.001","volume":"22","author":"HT Orr","year":"2012","unstructured":"Orr, H. T. Polyglutamine neurodegeneration: expanded glutamines enhance native functions. Curr. Opin. Genet. Dev. 22, 251\u2013255 (2012).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"12282_CR41","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.neuron.2010.08.034","volume":"67","author":"NB Nedelsky","year":"2010","unstructured":"Nedelsky, N. B. et al. Native functions of the androgen receptor are essential to pathogenesis in a Drosophila model of spinobulbar muscular atrophy. Neuron 67, 936\u2013952 (2010).","journal-title":"Neuron"},{"key":"12282_CR42","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/S0959-440X(97)80146-7","volume":"7","author":"F Sicheri","year":"1997","unstructured":"Sicheri, F. & Kuriyan, J. Structures of Src-family tyrosine kinases. Curr. Opin. Struct. Biol. 7, 777\u2013785 (1997).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"12282_CR43","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1146\/annurev.cellbio.13.1.513","volume":"13","author":"SM Thomas","year":"1997","unstructured":"Thomas, S. M. & Brugge, J. S. Cellular functions regulated by Src family kinases. Annu. Rev. Cell Dev. Biol. 13, 513\u2013609 (1997).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"12282_CR44","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/84675","volume":"7","author":"R Paul","year":"2001","unstructured":"Paul, R. et al. Src deficiency or blockade of Src activity in mice provides cerebral protection following stroke. Nat. Med. 7, 222\u2013227 (2001).","journal-title":"Nat. Med"},{"key":"12282_CR45","doi-asserted-by":"publisher","first-page":"23482","DOI":"10.1074\/jbc.M611269200","volume":"282","author":"S Khanna","year":"2007","unstructured":"Khanna, S., Roy, S., Park, H. A. & Sen, C. K. Regulation of c-Src activity in glutamate-induced neurodegeneration. J. Biol. Chem. 282, 23482\u201323490 (2007).","journal-title":"J. Biol. Chem."},{"key":"12282_CR46","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1038\/nn.3178","volume":"15","author":"JW Um","year":"2012","unstructured":"Um, J. W. et al. Alzheimer amyloid-beta oligomer bound to postsynaptic prion protein activates Fyn to impair neurons. Nat. Neurosci. 15, 1227\u20131235 (2012).","journal-title":"Nat. Neurosci."},{"key":"12282_CR47","doi-asserted-by":"publisher","first-page":"16857","DOI":"10.1523\/JNEUROSCI.1858-12.2012","volume":"32","author":"M Larson","year":"2012","unstructured":"Larson, M. et al. The complex PrP(c)-Fyn couples human oligomeric Abeta with pathological tau changes in Alzheimer\u2019s disease. J. Neurosci. 32, 16857\u201316871a (2012).","journal-title":"J. Neurosci."},{"key":"12282_CR48","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1002\/ana.24394","volume":"77","author":"AC Kaufman","year":"2015","unstructured":"Kaufman, A. C. et al. Fyn inhibition rescues established memory and synapse loss in Alzheimer mice. Ann. Neurol. 77, 953\u2013971 (2015).","journal-title":"Ann. Neurol."},{"key":"12282_CR49","doi-asserted-by":"crossref","unstructured":"Imamura, K., et al. The Src\/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis. Sci. Transl. Med. 9, 391 (2017).","DOI":"10.1126\/scitranslmed.aaf3962"},{"key":"12282_CR50","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1002\/pros.23119","volume":"76","author":"EM Posadas","year":"2016","unstructured":"Posadas, E. M. et al. Saracatinib as a metastasis inhibitor in metastatic castration-resistant prostate cancer: A University of Chicago Phase 2 Consortium and DOD\/PCF Prostate Cancer Clinical Trials Consortium Study. Prostate 76, 286\u2013293 (2016).","journal-title":"Prostate"},{"key":"12282_CR51","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s10637-015-0257-z","volume":"33","author":"SM Reddy","year":"2015","unstructured":"Reddy, S. M. et al. Phase II study of saracatinib (AZD0530) in patients with previously treated metastatic colorectal cancer. Invest. New Drugs 33, 977\u2013984 (2015).","journal-title":"Invest. New Drugs"},{"key":"12282_CR52","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.cellsig.2012.12.019","volume":"25","author":"A Barrett","year":"2013","unstructured":"Barrett, A., Pellet-Many, C., Zachary, I. C., Evans, I. M. & Frankel, P. p130Cas: a key signalling node in health and disease. Cell Signal 25, 766\u2013777 (2013).","journal-title":"Cell Signal"},{"key":"12282_CR53","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1111\/j.1349-7006.2004.tb02197.x","volume":"95","author":"H Zhang","year":"2004","unstructured":"Zhang, H. et al. Transforming growth factor-beta 1-induced apoptosis is blocked by beta 1-integrin-mediated mitogen-activated protein kinase activation in human hepatoma cells. Cancer Sci. 95, 878\u2013886 (2004).","journal-title":"Cancer Sci."},{"key":"12282_CR54","doi-asserted-by":"publisher","first-page":"34145","DOI":"10.1074\/jbc.M109.023614","volume":"284","author":"MK Wendt","year":"2009","unstructured":"Wendt, M. K., Smith, J. A. & Schiemann, W. P. p130Cas is required for mammary tumor growth and transforming growth factor-beta-mediated metastasis through regulation of Smad2\/3 activity. J. Biol. Chem. 284, 34145\u201334156 (2009).","journal-title":"J. Biol. Chem."},{"key":"12282_CR55","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1083\/jcb.145.7.1461","volume":"145","author":"M Oktay","year":"1999","unstructured":"Oktay, M., Wary, K. K., Dans, M., Birge, R. B. & Giancotti, F. G. Integrin-mediated activation of focal adhesion kinase is required for signaling to Jun NH2-terminal kinase and progression through the G1 phase of the cell cycle. J. Cell Biol. 145, 1461\u20131469 (1999).","journal-title":"J. Cell Biol."},{"key":"12282_CR56","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/S0092-8674(05)80018-2","volume":"81","author":"OA Coso","year":"1995","unstructured":"Coso, O. A. et al. The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK\/SAPK signaling pathway. Cell 81, 1137\u20131146 (1995).","journal-title":"Cell"},{"key":"12282_CR57","doi-asserted-by":"publisher","first-page":"5702","DOI":"10.1523\/JNEUROSCI.0388-10.2010","volume":"30","author":"M Katsuno","year":"2010","unstructured":"Katsuno, M. et al. Disrupted transforming growth factor-beta signaling in spinal and bulbar muscular atrophy. J. Neurosci. 30, 5702\u20135712 (2010).","journal-title":"J. Neurosci."},{"key":"12282_CR58","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/j.bbrc.2006.08.006","volume":"348","author":"N Hashimoto","year":"2006","unstructured":"Hashimoto, N. et al. Immortalization of human myogenic progenitor cell clone retaining multipotentiality. Biochem. Biophys. Res. Commun. 348, 1383\u20131388 (2006).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"12282_CR59","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/gt.2011.44","volume":"18","author":"K Shiomi","year":"2011","unstructured":"Shiomi, K. et al. CDK4 and cyclin D1 allow human myogenic cells to recapture growth property without compromising differentiation potential. Gene Ther. 18, 857\u2013866 (2011).","journal-title":"Gene Ther."},{"key":"12282_CR60","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nmeth.1591","volume":"8","author":"K Okita","year":"2011","unstructured":"Okita, K. et al. A more efficient method to generate integration-free human iPS cells. Nat. Methods 8, 409\u2013412 (2011).","journal-title":"Nat. Methods"},{"key":"12282_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-015-0172-4","volume":"8","author":"D Shimojo","year":"2015","unstructured":"Shimojo, D. et al. Rapid, efficient, and simple motor neuron differentiation from human pluripotent stem cells. Mol. Brain 8, 79 (2015).","journal-title":"Mol. Brain"},{"key":"12282_CR62","doi-asserted-by":"publisher","first-page":"3086","DOI":"10.1634\/stemcells.2008-0293","volume":"26","author":"Y Okada","year":"2008","unstructured":"Okada, Y. et al. Spatiotemporal recapitulation of central nervous system development by murine embryonic stem cell-derived neural stem\/progenitor cells. Stem Cells 26, 3086\u20133098 (2008).","journal-title":"Stem Cells"},{"key":"12282_CR63","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/nm1298","volume":"11","author":"M Waza","year":"2005","unstructured":"Waza, M. et al. 17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration. Nat. Med. 11, 1088\u20131095 (2005).","journal-title":"Nat. Med"},{"key":"12282_CR64","doi-asserted-by":"publisher","first-page":"11312","DOI":"10.1074\/jbc.275.15.11312","volume":"275","author":"WE Miller","year":"2000","unstructured":"Miller, W. E. et al. beta-arrestin1 interacts with the catalytic domain of the tyrosine kinase c-SRC. Role of beta-arrestin1-dependent targeting of c-SRC in receptor endocytosis. J. Biol. Chem. 275, 11312\u201311319 (2000).","journal-title":"J. Biol. Chem."},{"key":"12282_CR65","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1038\/sj.onc.1204173","volume":"20","author":"A Zvara","year":"2001","unstructured":"Zvara, A. et al. Activation of the focal adhesion kinase signaling pathway by structural alterations in the carboxyl-terminal region of c-Crk II. Oncogene 20, 951\u2013961 (2001).","journal-title":"Oncogene"},{"key":"12282_CR66","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/S0896-6273(02)00834-6","volume":"35","author":"M Katsuno","year":"2002","unstructured":"Katsuno, M. et al. Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Neuron 35, 843\u2013854 (2002).","journal-title":"Neuron"},{"key":"12282_CR67","doi-asserted-by":"publisher","first-page":"5115","DOI":"10.1523\/JNEUROSCI.1242-07.2007","volume":"27","author":"H Adachi","year":"2007","unstructured":"Adachi, H. et al. CHIP overexpression reduces mutant androgen receptor protein and ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model. J. Neurosci. 27, 5115\u20135126 (2007).","journal-title":"J. Neurosci."},{"key":"12282_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms2417","volume":"4","author":"N Kondo","year":"2013","unstructured":"Kondo, N. et al. Heat shock factor-1 influences pathological lesion distribution of polyglutamine-induced neurodegeneration. Nat. Commun. 4, 1405 (2013).","journal-title":"Nat. Commun."},{"key":"12282_CR69","doi-asserted-by":"publisher","unstructured":"Iida, M. et al. Src inhibition attenuates polyglutamine-mediated neuromuscular degeneration in spinal and bulbar muscular atrophy. Mendeley, https:\/\/doi.org\/10.17632\/sz4v5tcdyv.2 (2019).","DOI":"10.17632\/sz4v5tcdyv.2"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-12282-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-12282-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-12282-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T20:16:16Z","timestamp":1671221776000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-12282-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,19]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["12282"],"URL":"https:\/\/doi.org\/10.1038\/s41467-019-12282-7","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.736643799.793566726","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,19]]},"assertion":[{"value":"19 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4262"}}